Two climatetech startups are joining a new program from Greentown Labs and Browning the Green Space. Photo via greentownlabs.com

A new accelerator focused on BIPOC-led energy tech startups named its inaugural cohort, and two Houston-based companies made the cut.

The new program — Advancing Climatetech and Clean Energy Leaders Program, or ACCEL — is an initiative led by Greentown Labs and Browning the Green Space that was originally announced in November. The program was established to provide access to funding, networking connections, resources, and more to BIPOC-led startups working on a climatetech solution.

The program is supported by the Massachusetts Clean Energy Center, or MassCEC, a state economic development agency, and the Boston-based Barr Foundation, a Boston-based foundation. Each of the selected startups will receive a $25,000 grant, incubation at Greentown, mentorship from Greentown and BGS’s networks, and access to a curriculum curated by VentureWell, a nonprofit with deep expertise in the climatetech space.

“We are thrilled and eager to support this exceptional cohort of startup leaders as they tackle some of our world’s biggest climate challenges,” says Kevin T. Taylor, CFO and interim CEO at Greentown Labs, in a news release. “Through partnerships with Browning the Green Space and VentureWell—and with the support from MassCEC and the Barr Foundation—we look forward to offering intentional mentorship, training, and networking opportunities to help these BIPOC-led startups thrive.”

The co-located program will host startups at each of the two Greentown Labs locations in the Houston and Boston areas. The inaugural cohort includes:

  • Active Surfaces, based in Salem, Massachusetts, unlocks dual land-use applications through its ultra-thin-film, flexible solar technology. Its co-founders are Shivam Bhakta and Richard Swartwout.
  • Houston-based DrinKicks is a sneaker-themed consumer-products company that is focused on repurposing food waste and recycled materials into sustainable goods such as shoes, sports equipment, and clothing, all while educating consumers on the power of the circular economy. The company was co-founded by Kristeen Reynolds, Michael Fletcher, and Kristen Lee.
  • EarthBond, headquartered in Cambridge, Massachusetts, leverages group financing and carbon accounting to lower costs and risk in the energy transition of Nigeria's $14B fuel-based, off-grid generator market. Chidalu Onyenso founded the business.
  • Amherst, Massachusetts-based florrent is a bio-based materials and energy storage company providing solutions to address critical bottlenecks to the global decarbonization and electrification of utilities, transportation, and buildings. Its co-founders are Jose LaSalle, Joe Hastry, and Alexander Nichols. florrent is a current Greentown member.
  • frakktal, founded in Houston by Jhana Porter, is a B2B materials company developing bio-based polymer processes for the replacement of fossil-fuel-based feedstocks across industries. The company is a current Greentown member.
  • SpadXTech from Worcester, Massachusetts, is contributing to the reduction of CO2 emissions impacting several industries such as packaging, textiles, transportation, filtration, and construction through the manufacturing of its core and versatile material platform technology. Its co-founders are Lina M. González and Connor Crawford.

“We are inspired by and excited to support the wealth of innovation and fresh perspectives on climate solutions offered by our inaugural ACCEL cohort of startup leaders,” said Kerry Bowie, executive director and president of Browning the Green Space. “Through this partnership with Greentown Labs we are able to build critical support infrastructure for entrepreneurs of color and accelerate the equitable development and distribution of climate solutions across all communities.”

The program will officially kick off at an event on February 23 at Greentown’s Boston location.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Austin company to bring AI-powered school to The Woodlands

AI education

Austin-based Alpha School, which operates AI-powered private schools, is opening its first Houston-area location in The Woodlands.

The 8,000-square-foot school, scheduled to be ready for the 2026-27 academic year, initially will serve students in kindergarten through eighth grade. Alpha says the school will offer “open workshop spaces and innovative classrooms that support personalized instruction, core academics, leadership development, and real-world life skills.”

Alpha sets aside two hours each school day for the AI-driven, self-paced study of core subjects like math, reading and science. The rest of each school day consists of life-skills workshops focusing on topics such as leadership and financial literacy.

Alpha’s school in The Woodlands has begun accepting applications for the 2026-27 school year. Annual tuition costs $40,000.

“The Woodlands is one of the most dynamic, forward-thinking communities in Texas, and Alpha is proud to bring

an innovative educational model that complements its strong academic foundation,” says Rachel Goodlad, head

of expansion for Alpha.

Founded in 2014, Alpha School combines adaptive technology-driven instruction with immersive life-skills workshops. Its model emphasizes mastery-based learning in core subjects alongside development of communication, critical thinking, financial literacy and leadership skills. It operates more than 15 schools across the country.

Elsewhere in Texas, Alpha operates schools in Austin, Brownsville, Fort Worth and Plano. Alpha also operates 12 Texas Sports Academy campuses in Texas, including locations in Houston, Pearland and Richmond, along with a NextGen Academy esports school in Austin, a school for gifted students in Georgetown, and lower-cost Nova Academy campuses in Austin and Bastrop.

Alpha has fans and critics. While supporters tout students’ high achievement rates, detractors complain about the high tuition and the AI-influenced depersonalization of education.

“Students and our country need to be in relationship with other human beings,” Randi Weingarten, president of the American Federation of Teachers, a teachers union, tells The New York Times. “When you have a school that is strictly AI, it is violating that core precept of the human endeavor and of education.”

Alpha co-founder MacKenzie Price, a podcaster and social media influencer, doesn’t share Weingarten’s views.

“Parents and teachers: We need to embrace this change,” Price wrote after President Trump signed an executive order promoting AI in schools.

The Times notes that Alpha doesn’t employ AI as a tutor or a supplement. Rather, the newspaper says, AI is “the school’s primary educational driver to move students through academic content.”

Houston researcher secures $1.7M to develop drug for aggressive form of breast cancer

cancer research

A University of Houston researcher has joined a $3.2 million effort to develop a new drug designed to attack a cancer-driving protein commonly found in triple-negative breast cancer.

Triple-negative breast cancer (TNBC) is one of the most difficult-to-treat forms of cancer and accounts for 10 percent to 15 percent of all breast cancer cases. The disease gets its name because tumors associated with it test negative for estrogen receptors, progesterone receptors and excess HER2 protein, making it difficult to target. Due to this, TNBC is often treated with general chemotherapy, which can come with negative side effects and drug resistance, according to UH.

UH College of Pharmacy research associate professor Wei Wang is developing a drug that can target the disease more specifically. The drug will target MDM2, a protein often overproduced in TNBC that also contributes to faster tumor growth.

Wang is working on a team led by Wei Li, director of the University of Tennessee Health Science Center College of Pharmacy’s Drug Discovery Center. She has received $1.7 million to support the research.

Wang and UH professor of pharmacology and toxicology Ruiwen Zhang have discovered a compound that can break down MDM2. In early laboratory models, the compound has shown the ability to shrink tumors.

Wang and Zhang will focus on understanding how the treatment works and monitoring its effectiveness in models that closely mirror human disease.

“We will study how the drug targets MDM2 and evaluate the most promising drug candidates to determine effective dosing, understand how the drug behaves in the body, compare it with existing treatments and assess early safety,” Wang said in a news release.

Li’s team at the University of Tennessee will be working on the chemistry and drug design end of the project.

“This work could lead to an entirely new class of therapies for triple-negative breast cancer,” Li added in the release. “We’re hopeful that by directly removing the MDM2 protein from cancer cells, we can help more patients respond to treatment regardless of their tumor type.”